Xiaobin Yuan
Impact in
-
- Lung Cancer Treatments and Mutations
- Hematology top 10%
- Acute Myeloid Leukemia Research
Papers in
-
- Lung Cancer Treatments and Mutations 12
- Kidney Stones and Urolithiasis Treatments 3
- Renal cell carcinoma treatment 2
- Prostate Cancer Treatment and Research 1
- Urology 3
- Urological Disorders and Treatments 2
- Co-authors
- Charles L. Goldsmith (1 shared paper)David I. M. Forehand (1 shared paper)James C. M. Hwang (1 shared paper)Dongwen Wang (8 shared papers)Lieming Ding (7 shared papers)Xuhui Zhang (8 shared papers)Fenlai Tan (2 shared papers)Yinxiang Wang (1 shared paper)
- Journals
- PLoS ONE (3 papers)Journal of Thoracic Oncology (3 papers)BMC Urology (2 papers)The Lancet Respiratory Medicine (2 papers)BMJ Open (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Xiaobin Yuan
39 papers receiving 771 citations
Peers
Comparison fields: 5 of 77
- Pulmonary and Respiratory Medicine 279
- Hematology 89
- Oncology 163
- Genetics 51
- Cancer Research 60
Countries citing papers authored by Xiaobin Yuan
This map shows the geographic impact of Xiaobin Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Yuan more than expected).
Fields of papers citing papers by Xiaobin Yuan
This network shows the impact of papers produced by Xiaobin Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Yuan. The network helps show where Xiaobin Yuan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobin Yuan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 146 | |
| 2 | 2019 | 113 | |
| 3 | 2005 | 94 | |
| 4 | 2023 | 56 | |
| 5 | 2015 | 39 | |
| 6 | 2020 | 36 | |
| 7 | 2021 | 32 | |
| 8 | 2015 | 29 | |
| 9 | 2022 | 23 | |
| 10 | 2007 | 23 | |
| 11 | 2022 | 20 | |
| 12 | Studies on tabellae indigo naturalis in treatment of psoriasis. | 1982 | 19 |
| 13 | 2021 | 15 | |
| 14 | 2021 | 14 | |
| 15 | 2022 | 14 | |
| 16 | 2022 | 11 | |
| 17 | 2015 | 11 | |
| 18 | 2011 | 10 | |
| 19 | 2025 | 8 | |
| 20 | 2011 | 7 |
About Xiaobin Yuan
Xiaobin Yuan is a scholar working on Pulmonary and Respiratory Medicine, Urology, Statistics and Probability, Genetics and Surgery, having authored 42 papers that have together received 786 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Kidney Stones and Urolithiasis Treatments (3 papers), Statistical Methods in Clinical Trials (2 papers), Renal cell carcinoma treatment (2 papers), HER2/EGFR in Cancer Research (2 papers), Urological Disorders and Treatments (2 papers), Adrenal and Paraganglionic Tumors (2 papers) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (279 citations), Hematology (89 citations), Oncology (163 citations), Genetics (51 citations) and Cancer Research (60 citations). Xiaobin Yuan has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Charles L. Goldsmith, David I. M. Forehand, James C. M. Hwang, Dongwen Wang, Lieming Ding, Xuhui Zhang, Fenlai Tan, Yinxiang Wang, Shesh Nath Rai and Yuankai Shi. Their work appears in journals such as PLoS ONE, Journal of Thoracic Oncology, BMC Urology, The Lancet Respiratory Medicine and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.